BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28688694)

  • 1. Nutritional changes in patients with locally advanced head and neck cancer during treatment.
    Arribas L; Hurtós L; Taberna M; Peiró I; Vilajosana E; Lozano A; Vazquez S; Mesia R; Virgili N
    Oral Oncol; 2017 Aug; 71():67-74. PubMed ID: 28688694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Nutrition Impact Symptoms, Nutritional and Functional Status during Head and Neck Cancer Treatment.
    Neoh MK; Abu Zaid Z; Mat Daud ZA; Md Yusop NB; Ibrahim Z; Abdul Rahman Z; Jamhuri N
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32357529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioelectrical impedance phase angle as indicator and predictor of cachexia in head and neck cancer patients treated with (chemo)radiotherapy.
    Stegel P; Kozjek NR; Brumen BA; Strojan P
    Eur J Clin Nutr; 2016 May; 70(5):602-6. PubMed ID: 26908426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
    Talwar B; Donnelly R; Skelly R; Donaldson M
    J Laryngol Otol; 2016 May; 130(S2):S32-S40. PubMed ID: 27841109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy.
    Moon H; Roh JL; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
    Radiother Oncol; 2016 Feb; 118(2):330-4. PubMed ID: 26653356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
    Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
    Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-therapeutic nutritional assessment for predicting severe adverse events in patients with head and neck cancer treated by radiotherapy.
    Kono T; Sakamoto K; Shinden S; Ogawa K
    Clin Nutr; 2017 Dec; 36(6):1681-1685. PubMed ID: 27847115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil combined with cisplatin concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: a matched pair analysis.
    Teo M; Karakaya E; Young CA; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):647-53. PubMed ID: 23948462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Nakashima T; Hasegawa Y
    Auris Nasus Larynx; 2015 Apr; 42(2):150-5. PubMed ID: 25498333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment albumin level predicts survival in head and neck squamous cell carcinoma.
    Lim WS; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
    Laryngoscope; 2017 Dec; 127(12):E437-E442. PubMed ID: 28561532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer.
    Wang HM; Lin CY; Hsieh CH; Hsu CL; Fan KH; Chang JT; Huang SF; Kang CJ; Liao CT; Ng SH; Yen TC
    J Formos Med Assoc; 2017 Mar; 116(3):185-192. PubMed ID: 27133181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive resistance training in head and neck cancer patients during concomitant chemoradiotherapy -- design of the DAHANCA 31 randomized trial.
    Lonkvist CK; Lønbro S; Vinther A; Zerahn B; Rosenbom E; Primdahl H; Hojman P; Gehl J
    BMC Cancer; 2017 Jun; 17(1):400. PubMed ID: 28578654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Planned neck dissection in the treatment of locally advanced head and neck squamous cell carcinoma].
    Jiang L; Lou JL; Wang KJ; Fang MY; Fu ZF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):92-96. PubMed ID: 29429177
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy.
    Visacri MB; Ferrari GB; Dias P; Pimentel R; de Souza CM; Costa AP; de Carvalho Pincinato E; Lima CS; Mazzola PG; Moriel P
    South Med J; 2015 Jun; 108(6):343-9. PubMed ID: 26079459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disease-specific enteral nutrition formula improves nutritional status and functional performance in patients with head and neck and esophageal cancer undergoing chemoradiotherapy: results of a randomized, controlled, multicenter trial.
    Fietkau R; Lewitzki V; Kuhnt T; Hölscher T; Hess CF; Berger B; Wiegel T; Rödel C; Niewald M; Hermann RM; Lubgan D
    Cancer; 2013 Sep; 119(18):3343-53. PubMed ID: 23765693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.
    Karakaya E; Yetmen O; Oksuz DC; Dyker KE; Coyle C; Sen M; Prestwich RJ
    Oral Oncol; 2013 Jan; 49(1):55-9. PubMed ID: 22858313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of factors predicting malnutrition in patients with advanced head and neck cancer.
    Silander E; Nyman J; Hammerlid E
    Laryngoscope; 2013 Oct; 123(10):2428-34. PubMed ID: 23918730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer.
    Lin YC; Ling HH; Chang PH; Pan YP; Wang CH; Chou WC; Chen FP; Yeh KY
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tube feeding during treatment for head and neck cancer - Adherence and patient reported barriers.
    Brown T; Banks M; Hughes BGM; Lin C; Kenny L; Bauer J
    Oral Oncol; 2017 Sep; 72():140-149. PubMed ID: 28797450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.